Revolutions Medical Signs Distribution Agreement With McKesson
(firmenpresse) - CHARLESTON, SC -- (Marketwire) -- 11/16/12 -- Revolutions Medical Corporation (OTCQB: RMCP) announced today that the Company has entered into a vendor and distribution agreement with McKesson Corporation ("McKesson") for the distribution of the Company's RevVac™ auto-retractable vacuum safety syringe in the United States healthcare market. McKesson is one of the leading medical-surgical supply and distribution companies in the United States, while also serving as one of the country's largest pharmaceutical distributors, supplying more than 40,000 pharmacy locations across the U.S. Pursuant to the terms of the vendor and distribution agreement, the RevVac™ auto-retractable vacuum safety syringe is now available to over 550 McKesson sales representatives through their distribution network and order processing system.
Ron Wheet, the Company's Chief Executive Officer and Chairman, stated, "Since introducing the RevVac™ safety syringe to the U.S. health care market in the second quarter 2012, the Company has considered several available options to best manage the roll out of our product. We are very pleased to have the RevVac™ safety syringe distributed by McKesson, one of the best names in health care quality in the world. We believe this relationship will complement our additional sales efforts with MedPro Associates."
About Revolutions Medical Corporation
Revolutions Medical Corporation is a safety medical device and software application company. Its proprietary technologies and products include: the RevVac™ safety syringe, safety blood drawing device, the RevColor™, RevDisplay™, and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS) and prefilled vacuum auto-retraction safety syringes.
For additional information, please visit Revolutions Medical corporate website:
To be added to the Revolutions Medical investor email list, please email:
with RMCP in the subject line.
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
CONTACT:
Revolutions Medical Corporation
Investor Relations
Tel.: (843) 606-9461
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 16.11.2012 - 12:32 Uhr
Sprache: Deutsch
News-ID 1172283
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
CHARLESTON, SC
Phone:
Kategorie:
Medical Devices
Anmerkungen:
Diese Pressemitteilung wurde bisher 192 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Revolutions Medical Signs Distribution Agreement With McKesson
"
steht unter der journalistisch-redaktionellen Verantwortung von
Revolutions Medical Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
